# Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds

> **NCT00189475** · PHASE4 · COMPLETED · sponsor: **Deborah Gentile** · enrollment: 84 (actual)

## Conditions studied

- Upper Respiratory Infection

## Interventions

- **DRUG:** Montelukast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00189475
- **Lead sponsor:** Deborah Gentile
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2020-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189475, "Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00189475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*